KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism

Miceli, F., Millevert, C., Soldovieri, M. V., Mosca, I., Ambrosino, P., Carotenuto, L., Schrader, D., Lee, H. K., Riviello, J., Hong, W., Risen, S., Emrick, L., Amin, H., Ville, D., Edery, P., de Bellescize, J., Michaud, V., Van-Gils, J., Goizet, C., … Weckhuysen, S. (2022). KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism. EBioMedicine, 81, 104130. https://doi.org/10.1016/j.ebiom.2022.104130
Authors:
Francesco Miceli
Charissa Millevert
Maria Virginia Soldovieri
Ilaria Mosca
Paolo Ambrosino
Lidia Carotenuto
Dewi Schrader
Hyun Kyung Lee
James Riviello
William Hong
Sarah Risen
Lisa Emrick
Hitha Amin
Dorothée Ville
Patrick Edery
Julitta de Bellescize
Vincent Michaud
Julien Van-Gils
Cyril Goizet
Marjolein H Willemsen
Tjitske Kleefstra
Rikke S Møller
Allan Bayat
Orrin Devinsky
Tristan Sands
G Christoph Korenke
Gerhard Kluger
Heather C Mefford
Eva Brilstra
Gaetan Lesca
Mathieu Milh
Edward C Cooper
Maurizio Taglialatela
Sarah Weckhuysen
Affiliated Authors:
Tristan Sands
Author Keywords:
kcnq2
gain-of-function
amitriptyline
autism
developmental and epileptic encephalopathy
Publication Type:
Article
Unique ID:
10.1016/j.ebiom.2022.104130
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: